|
|
1 avenue Claude Vellefaux, Hopital Saint-Louis
Paris, 75010 France
phone: +33 (0)1 400 308 18
fax:+33 (0)1 400 308 28
|
|
| Symbol |
Private |
| Founded |
1998 |
| Employees |
|
|
|
| www.urogene.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| drug discovery and development company focused on therapies for urology disorders |
|
| Management |
| Pierre Attali, MD, Chief Executive Officer; Hugues Bienaym, PhD, Managing Director & CSO; Christian Grenier, Chairman of the Board; Pr Pierre Teillac, Gilles Schang, Claude Stoufs |
| |
|
|
| |
|
| Keywords |
| Urology, Urology, prostate, urinary, bladder, erectile, urinary, bladder, erectile |
|
|
|
| Description |
|
UroGene SA is a drug discovery and development company focused on therapies for urology disorders. The company has developed a tissue and data bank to fuel a sustainable pipeline of new potential therapeutic targets in onco-urology. |
|
|
| Funding |
| Urogene raised over 15 million euros from leading venture capitalists since inception in 1998. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members